Here’s how Covid-19 has affected funding, development in infectious diseases July 21, 2020 Auto Bot ARCH Venture Partners, BioPharma, Chicago, Illinois, invest 2020 virtual, MedCity INVEST, SARS-CoV-2, Startups 0 “Everybody’s an infectious disease company now,” ARCH Venture Partners Managing Director Bob Nelsen said. By contrast, a report last year showed a huge decline in venture capital investment in the infectious disease space.